RT @MarcJacksonLA: $PMVP PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Tar…
RT @MarcJacksonLA: $PMVP PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Tar…
© Nextech Invest Ltd. | privacy policy